000 | 01279 a2200349 4500 | ||
---|---|---|---|
005 | 20250517231101.0 | ||
264 | 0 | _c20190923 | |
008 | 201909s 0 0 eng d | ||
022 | _a1879-016X | ||
024 | 7 |
_a10.1016/j.pharmthera.2018.07.003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSoendergaard, Christoffer | |
245 | 0 | 0 |
_aTargeting JAK-STAT signal transduction in IBD. _h[electronic resource] |
260 |
_bPharmacology & therapeutics _c12 2018 |
||
300 |
_a100-111 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
650 | 0 | 4 |
_aJanus Kinase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aJanus Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aSTAT Transcription Factors _xmetabolism |
650 | 0 | 4 | _aSignal Transduction |
700 | 1 | _aBergenheim, Fredrik Holmberg | |
700 | 1 | _aBjerrum, Jakob Tveiten | |
700 | 1 | _aNielsen, Ole Haagen | |
773 | 0 |
_tPharmacology & therapeutics _gvol. 192 _gp. 100-111 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharmthera.2018.07.003 _zAvailable from publisher's website |
999 |
_c28672122 _d28672122 |